CVS HEALTH Corp
For the period ended Dec 31, 2023. Filed Feb 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
No events have occurred during the fourth quarter ended December 31, 2023 that would require disclosure under this item.
Securities Trading Plans of Directors and Executive Officers
During the year ended December 31, 2023, none of our directors or executive officers adopted orterminated any contract, instruction or written plan for the purchase or sale of CVS Health Corporation securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.